Marker Therapeutics, Inc. (MRKR) at a glance

Marker Therapeutics, Inc. (MRKR) is a Healthcare company. It trades at $1.33. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (24/100).

Price
$1.34
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$0.81 to $4.07
Vestovix Score47/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
24